🤝 Fertifa acquires Juniper to become Europe's top reproductive health benefits provider

The deal unites two benefits industry pioneers into a single integrated solution for employee reproductive health and neurodiversity support.

"Juniper’s vision for solving the critical need for reproductive healthcare is perfectly aligned with our own. This acquisition is a significant step forward in our mission to dismantle barriers to care."

— Eileen Burbidge, Executive Director at Fertifa

🔗 Read More

‍

🚀 Ovasave raises $1.2M to expand fertility care across GCC

UAE-based Ovasave, a Hub71 FemTech startup, secured $1.2 million in pre-seed funding led by PlusVC, Annex Investments, and New York-based 25 Madison.

“This funding marks a crucial step in our mission to disrupt women’s health and expand access to fertility and hormonal care across the region.”

— Torkia Mahloul, Co-Founder & CEO at Ovasave

🔗 Read More

‍

💼 Clue partners with Ben to offer workplace period tracking benefits

The menstrual health app has teamed up with employee benefits platform Ben to provide Clue Plus subscriptions free to employees at major companies including Mondelēz International, Virgin, Deliveroo, Octopus Energy, and itsu.

PLUS! Rhiannon White, CEO, Clue will be speaking at WHW Europe 🎉

🔗 Read More

‍

💊 Gesynta Pharma raises SEK 347M Series B for endometriosis drug development

The Swedish biotech secured an additional SEK 43 million in its second closing, with new investors HealthCap and Hadean Growth Fund joining the round led by Innovestor Life Science.

"This investment reflects our strong confidence in Gesynta Pharma's vision and its potential to deliver a genuine breakthrough in women's health."

— Kristina Ekberg, Partner at HealthCap

🔗 Read More

‍

✅ FDA clears Neuspera's integrated sacral neuromodulation system for urinary incontinence

The FDA approved Neuspera Medical's integrated sacral neuromodulation (iSNM) system as an alternative treatment for patients with urinary urge incontinence, with clinical data showing 84.2% of patients achieved at least a 50% reduction in urgent leaks.

🔗 Read More

‍

🌎 Boehringer Ingelheim invests in Kasha Global to boost African women's healthcare access

Boehringer Ingelheim's Social Engagement Fund backed the African startup that combines online and offline distribution to deliver pharmaceuticals and health products to low-income communities.

“Kasha is excited to partner with Boehringer in our shared mission of realizing last mile access to health products for the mass market.”

— Joanna Bichsel, Founder & CEO at Kasha Global

🔗 Read More

‍

Another big week! Let us know what you're working on, or who we should feature next.

‍Email us at info@womenshealthweek.com and put "Scoop Request" as the subject!